“Roxas Amendments” consistent with US Appellate Court Decision on Norvasc

Senator Mar Roxas expressed victory over the recent decision of the United States’ highest appellate court invalidating the patent of Pfizer over amlodipine besylate, a hypertension drug under the brand name Norvasc.

He said the decision last week of the US Court of Appeals for the Federal Circuit is consistent with his proposed amendments to the Intellectual Property Code, or Senate Bill No. 2263, also known as the cheaper medicines bill. (Senate)